Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal vs. Intravenous Paracetamol for PDA in Neonates
NCT06256211Phase 2Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms). Primary endpoint: Rate of efficiency of Rectal and Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus at 1 year. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT06256211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256211.